Inhibitor of growth 4 (ING4) is a member of the ING family of tumor suppressor proteins. In this study, we have analyzed the impact of two mutations in ING4 associated with human tumors (Y121N and N214D), testing their behavior in a series of functional, biochemical and structural analyses. We report that the N214D mutation dramatically dampened the ability of ING4 to inhibit proliferation, anchorage-independent growth or cell migration or to sensitize to cell death. In turn, the Y121N mutant did not differ significantly from wild-type ING4 in our assays. Neither of the mutations altered the normal subcellular localization of ING4, showing predominantly nuclear accumulation. We investigated the molecular basis of the defect in the activity of the N214D mutant. The folding and ability to bind histone marks of ING4 was not significantly altered by this mutation. Instead, we found that the functional impairment of the N214D mutant correlates with reduced protein stability due to increased proteasomemediated degradation. In summary, our data demonstrates that a point mutation of ING4 associated to human tumors leads to the loss of several essential functions of ING4 pertinent to tumor protection and highlight the importance of ING4 function to prevent tumorigenesis.
Inhibitor of growth 4 (ING4) is a member of the ING family of tumor suppressor proteins. In this study, we have analyzed the impact of two mutations in ING4 associated with human tumors (Y121N and N214D), testing their behavior in a series of functional, biochemical and structural analyses. We report that the N214D mutation dramatically dampened the ability of ING4 to inhibit proliferation, anchorage-independent growth or cell migration or to sensitize to cell death. In turn, the Y121N mutant did not differ significantly from wild-type ING4 in our assays. Neither of the mutations altered the normal subcellular localization of ING4, showing predominantly nuclear accumulation. We investigated the molecular basis of the defect in the activity of the N214D mutant. The folding and ability to bind histone marks of ING4 was not significantly altered by this mutation. Instead, we found that the functional impairment of the N214D mutant correlates with reduced protein stability due to increased proteasomemediated degradation. In summary, our data demonstrates that a point mutation of ING4 associated to human tumors leads to the loss of several essential functions of ING4 pertinent to tumor protection and highlight the importance of ING4 function to prevent tumorigenesis.
Introduction
Mammalian cells possess protective mechanisms that prevent tumor initiation and progression (1, 2) . The ING proteins constitute a family of evolutionary conserved proteins with important roles in different responses associated with tumor protection, such as apoptosis, DNA repair or cellular senescence (3) . In mammals, the ING family includes five loci (ING1-ING5), some of which produce several protein variants by alternative splicing. Inhibitor of growth 4 (ING4) is a member of the ING family with a role in cellular processes critical for tumor initiation and progression. ING4 can regulate apoptosis (4) and proliferation, in common with other ING proteins, but also has a specific role in anchorage-independent growth (5), angiogenesis (6, 7) , cell migration (8, 9) or response to hypoxia (6, 10, 11) . Like other ING proteins, ING4 exerts its function mainly as a chromatin regulator, linking histone marks to complexes with histone-modifying activities. ING4 specifically binds H3K4me3 (histone H3 trimethylated at lysine 4, a distinctive mark of euchromatin) through its plant homeodomain (PHD) domain (12) (13) (14) (15) , and it is also a component of complexes with histone acetyltransferase activity, in connection with HBO1 (7, 16, 17) . ING4 can also cooperate with p53 and nuclear factor-kappaB in transcriptional control, contributing to p53 posttranslational modifications or as a cofactor for both (18) (19) (20) . Alterations in the ING4 locus have been described in diverse human tumors, including glioma, myeloma, breast carcinoma or head and neck squamous cell carcinoma (3, 5, 17, 21) . Reduced levels of ING4 messenger RNA or protein are the most prevalent alterations of ING4 in tumors. In addition, there are also examples of short deletions and insertions or point mutations that result in truncations or amino acid changes in the ING4 protein sequence (5, 22, 23) . Given the proposed role of ING4 in preventing tumor initiation and progression, here we sought to study the functional impact of point mutations in ING4 associated with human tumors, with the aim to obtain insights on the role of this protein in tumor suppression.
Materials and methods

Mutagenesis
Mutant versions of ING4 were generated with the Quick Change Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA), using the complementary DNA of the human ING4 protein cloned in the retroviral vector pLPC as a template (variant v1; 24) cloned in the retroviral vector pLPC. Specific mutations were incorporated by polymerase chain reaction using Pfu Turbo DNA Polymerase (Stratagene), and subsequent digestion with DpnI, to eliminate the methylated parental band. They were confirmed by sequencing.
Cell culture
Immortalized mouse fibroblasts (NIH3T3) and the human cell lines U2OS (osteosarcoma), HT1080 (fibrosarcoma) H23 and H82 (lung carcinoma), and 293T (embryonic kidney epithelium) were cultured in Dulbecco's modified Eagle's medium (Gibco, Grand Island, NY), containing 10% fetal calf serum, in the presence of penicillin-streptomycin, at 37°C and 5% CO 2 . Human microvascular endothelial cells (HMVEC) were grown in MCDB 131 medium (Sigma, St Louis, MO), supplemented with 10% fetal calf serum, 2 mM L-glutamine, 10 ng/ml epidermal growth factor, 10 ng/ml hydrocortisone and 16.32 lg/ml bovine pituitary extract (Invitrogen, Carlsbad, CA).
Transfections
Transient transfection of 293T cells was performed using the calcium phosphate method, as described previously (25, 26) . Transient transfection of U2OS cells was carried out with FuGENE (Roche, Manheim, Germany), following the manufacturer's protocol.
Retroviral infection
Retroviral infection of NIH3T3 cells was performed essentially as described previously (26) . The following vectors were used: pLPC, pLPC- AU5-ING4,  pLPC-AU5-ING4   Y121N   , pLPC-AU5-ING4  N214D , pLPC-HA-ING4, pLPC-HA-ING4 N214D , pWZLHygro and pWZL Hygro-RasV12.
Immunoblot
The preparation of total cell lysates, electrophoresis and western blot analysis was carried out as described in ref. 27 . The antibodies used were anti-ING4 (ab3714, 1:500 dilution; AbCam, Cambridge, UK), anti-AU5 (MMS-135R, 1:500 dilution; Covance, Princeton, NJ) and anti-hemmaglutinin (Hybridoma clone 12CA5, 1:500 dilution). We used an anti-actin antibody (AC-15, 1:10 000 dilution; Sigma) as a loading control.
Reverse transcription-polymerase chain reaction Total RNA was prepared using Tri Reagent (Sigma) from cells growing asynchronously. Five micrograms of total RNA was used for complementary DNA synthesis using M-MLV reverse transcriptase (Promega, Madison, WI). One microliter of the reaction was used to perform polymerase chain reactions. The oligos used were as follows: ING4 forward, 5#-ATTGCCTTTGTCAC-CAGGTC-3# and ING4 reverse, 5#-GGAACCACTCGATGGAACAA-3#. Quantitative polymerase chain reaction was performed using Universal Probe Library probes in an ABI 9700 machine. 
DNA synthesis rate
Cell migration assays
The assays were conducted using modified Boyden chambers with 0.5% gelatin-coated polycarbonate membranes (6.5 mm diameter, 8.0 lm pore size; Corning Incorporated, Corning, NY). To obtain the conditioned medium, retrovirally infected NIH3T3 cells were grown until 80% confluence and, after extensive washing with phosphate-buffered saline, were maintained in serumfree medium for 48 h. Subsequently, the collected media were concentrated 60-fold using Ultra-15 concentrators (Millipore Corporation, Billerica, MA). HMVEC, serum-starved for 16 h, were plated in serum-free MCDB 131 medium on the upper chamber of the Transwell (1.2 Â 10 5 cells), whereas conditioned medium (15 lg/ml in serum-free medium) was placed in the lower chamber. Cells were allowed to migrate for 18 h at 37°C and non-migrated cells were removed from the top chamber with a cotton swab. Migrated cells were fixed and stained with Diff-Quik (Dade Behring, Newark, NJ) and counted at 20 fields of maximum migration under a light microscope at Â40 magnification. 
Cell viability assays
Anchorage-independent growth NIH3T3 cells infected with ING4
N214D mutant and wild-type ING4 were reinfected with a vector carrying the oncogenic version of Ha-Ras (pWZLHygroRasV12) or empty vector as a control. Infected cells were resuspended in a pre-warmed solution of 0.3% agarose in complete medium and plated on 60 mm plates with a bottom layer of 0.5% agarose, at a density of 10 5 cells per plate. Colonies were visually counted after 15 days.
Nuclear magnetic resonance spectroscopy and structure determination Nuclear magnetic resonance (NMR) experiments were recorded on Bruker AVANCEII 600 MHz (with cryoprobe) and 700 MHz spectrometers at 25°C in 20 mM sodium phosphate pH 6.5, 50 mM NaCl, 1 mM perdeuterated dithiothreitol and 9% (vol/vol) 2H 2 O. Backbone and side chain resonance assignment were obtained using a set of 2D and 3D NMR spectra recorded on a 0.5 mM PHD N214D sample uniformly enriched in 15 N. Distance restraints collected from NOESY spectra were used to calculate an ensemble of models using torsion angle dynamics. Further details are given as supplementary data, available at Carcinogenesis Online.
Binding to histone marks Synthetic lyophilized peptides were purchased from PolyPeptide, Strasbourg, France. They contained the sequences ARTKQTARKSTGGKAY, histone H3 residues 1-15 and GGAKRHKVLRDNIQY, histone H4 residues 14-27, with an extra Tyr residue at the C-termini to measure the peptide concentration by absorbance. Peptides with trimethylated lysine at positions 4 or 9 of histone H3 or position 20 of histone H4 were tested for binding to ING4-PHD
N214D
. The binding and dissociation constant were measured by NMR spectroscopy as described above.
Protein half-life assays
The 293T cells were transiently transfected with ING4 constructions, using calcium phosphate. At 36 h post-transfection, cycloheximide was added to the medium at a final concentration of 50 lg/ml to inhibit protein synthesis. The proteasome inhibitors MG132 (Sigma) or lactacystin (Calbiochem, San Diego, CA) were added 1 h before the start of treatment with cycloheximide at a final concentration of 20 or 10 lM, respectively. The lysates were analyzed by immunoblot using an anti-hemmaglutinin antibody.
Results
Cell proliferation
We generated mutant versions of the human ING4 protein, which included two missense point mutations detected in lung carcinoma cell lines (29) . The Y121N mutation is located close to the nuclear localization signal , whereas the N214D mutation is within the conserved PHD domain, next to a residue involved in the interaction with Cancer-associated mutations in ING4 methylated histone (D213; 12) and near two cysteine residues (C212 and C217), responsible for the maintenance of the PHD domain structure ( Figure 1A) . We confirmed that all the ING4 variants were efficiently expressed ( Figure 1B ). Using immunofluorescence, we observed that both mutant forms of ING4 displayed a subcellular distribution indistinguishable from the wild-type version, with predominantly nuclear localization and limited cytoplasmic expression ( Figure 1C) . ING4 overexpression has a clear antiproliferative effect zin several different cell types (4, 24) . This is one of the bestcharacterized phenotypes for ING4, so we decided to start our study by testing the behavior of cancer-associated ING4 mutants in this context. The rate of DNA synthesis was estimated by BrdU incorporation in asynchronous populations of NIH3T3 cells infected with empty vector or vectors encoding wild-type ING4 and both mutants, ING4 N214D and ING4 Y121N ( Figure 1D 
Cell migration
Increased cell migration, invasion and angiogenic potential are distinctive features of tumor cells, associated with their metastatic capacity. ING4 is unique among ING proteins in that it can inhibit the angiogenic potential of tumor cells and represses migration and invasion in these cells (9, 24, 30) . Thus, we decided to determine whether these properties were altered in the ING4 cancer mutants. The anti-migratory function of ING4 is exerted mainly in a non-cellautonomous fashion, through the repression of promigratory-secreted factors (6, 7, 17, 31) . For this reason, conditioned medium of cells expressing different versions of ING4 were used in migration assays, to test their ability as a chemotactic substrate for human microvascular endothelial cells, HMVEC (Figure 2) . Consistent with the role of ING4 as a negative regulator of cell migration and angiogenesis, the medium from cells expressing wild-type ING4 was less efficient in induction of migration ($60% of the control cells). In contrast, the effect on cell migration of conditioned medium from cells expressing the N214D mutant was undistinguishable from that of control vectorinfected cells. In this assay, the mutant ING4 Y121N had no significant functional impact, leading to levels of migration similar to those obtained for wild-type ING4, in line with the results obtained in the proliferation assay. Similar results were obtained in migration assays of HMVEC with independent constructs of ING4 that contained a different tag (supplementary Figure 1A is available at Carcinogenesis Online). The impact of cancer mutations in the cell-autonomous antimigratory action of ING4 was also determined in wound healing assays with NIH3T3 cells expressing wild-type or mutant ING4, leading to similar conclusions (supplementary Figure 1B is available at Carcinogenesis Online).
Anchorage-independent growth ING4 was isolated in a screening for proteins with the ability to revert the loss of anchorage dependence, a hallmark of transformed cells (12) . To analyze the impact of ING4 cancer mutations in this context, NIH3T3 cells infected with ING4 constructs or empty vector were oncogenically transformed with an activated Ha-Ras oncogene (RasV12). Cells were then allowed to grow in soft agar for 15 days and the number of colonies at the end of the experiment was counted (Figure 3) . The ING4 Y121N protein was not further analyzed because it displayed wild-type activity in the assays described above. The ability of Ras-expressing NIH3T3 cells to form colonies in soft agar was significantly reduced by the concomitant overexpression of the wild-type form of ING4, when compared with control cells expressing Ras and an empty vector (30% reduction). However, this inhibitory effect was lost in Ras-NIH3T3 fibroblasts co-expressing the mutant N214D, which displayed an ability to form colonies not significantly different to control cells.
Impact on cell viability
Overexpression of ING4 can lead to increased cell death, either alone or in synergy with DNA damaging agents (12) . To test the impact of cancer-associated mutations in this function of ING4, we performed a cell viability assay in NIH3T3 fibroblasts infected with ING4 wt and ING4 N214D . Cells were treated with doxorubicin, an agent that causes DNA damage, and we scored the ability of the different ING4 versions to sensitize this agent. As expected, wild-type ING4 expression caused a dramatic increase in doxorubicin-triggered cell death ($3-fold), but this effect was almost completely abolished in fibroblasts expressing the mutant version ING4 N214D (Figure 4) . Similar results were obtained with the human tumor cell line HT1080 (supplementary Figure 2 is available at Carcinogenesis Online). A.Moreno et al.
Impact on protein structure and binding to histone marks
Since the presence of the N214D mutation consistently led to the reduced activity of ING4 in several functional assays, we set to establish the molecular mechanism underlying this apparent loss of function. First, we investigated the effects of the N214D mutation in the folding of the ING4 molecule and in recognition of histone marks. To study the impact in protein structure, the N214D mutant PHD domain was analyzed in solution by NMR. Full structure determination and refinement (supplementary Table 1 is available at Carcinogenesis Online) showed that the three-dimensional structure for residues 195-244 is essentially the same as for wild-type ING4, whereas the NMR signals of the chain termini are highly flexible in the two molecules. [ Figure 5A , see also (13) ]. The pattern of backbone 1 H-15 N signals in the heteronuclear single quantium correlation spectrum displayed significant differences between mutant and wildtype PHDs (supplementary Figure 3A and B is available at Carcinogenesis Online), caused by the local change in the chemical environment due to the addition of a negative charge at the end of a short side chain in the N214D mutant, which affects the nearby residues on the structured protein. We also used NMR to test the ability of mutant ING4 to bind histone marks. Wild-type ING4, like other ING proteins, can specifically recognize the histone mark H3K4me3 through its PHD domain (12, 13, 32) . We observed that the ING4-PHD N214D mutant also binds preferentially to the H3K4me3 mark, using the same site as the wild-type PHD (
Figure 5B 
Impact on protein stability
During the course of our experiments, we consistently observed reduced levels of the ING4 N214D protein, relative to the wild-type form, in fibroblasts stably expressing the different forms of ING4 ( Figure 6A , left, see also Figure 1B ). However, wild-type and mutant ING4 constructs were expressed similarly at RNA level, with slightly elevated RNA expression for ING4 N214D ( Figure 6A , right). These results suggested that the N214D mutation could cause a defect in ING4 protein stability. To investigate the effects of this mutation on the turnover of the ING4 protein, we performed half-life experiments in 293T cells transiently transfected with vectors expressing hemmaglutinin-tagged ING4 wt and ING4 N214D and subsequently treated with cycloheximide ( Figure 6B and C). The decline of the amount of the N214D protein was considerably faster than for wildtype ING4 ( Figure 6B , left, and Figure 6C ). It has been recently reported that ING4 protein levels are controlled by proteasomemediated degradation (34) . To evaluate the link of the reduced protein stability of the N214D mutant to the proteasome pathway, half-life experiments were performed in the presence of the proteasome inhibitor MG132. MG132 reversed the reduced stability of the N214D mutant, leading to increased half-lives of both mutant and wild-type proteins ( Figure 6B , right, and Figure 6C ). Similar results were obtained with lactacystin, another proteasome inhibitor (supplementary Figure 4 is available at Carcinogenesis Online). It has been suggested that the stability of ING4 depends on its accumulation in the nucleolus and its association to the tumor suppressor protein alternative reading frame (ARF) (34) . In contrast, our immunofluorescence analyses consistently showed a predominantly nuclear localization for wild-type or mutant ING4, without accumulation in the nucleolus, even with nucleolar exclusion in some instances. Accordingly, no colocalization with the nucleolar protein ARF was observed for any of the ING4 versions analyzed ( Figure 1C ; supplementary Figure 5 is available at Carcinogenesis Online). Of note, our results could be confirmed with cell lines expressing endogenous mutant ING4. We observed reduced levels of endogenous ING4 protein in the small-cell lung carcinoma cell line H82, which harbors the mutant allele N214D, relative to H23, a lung adenocarcinoma line with the Y121N mutation (5; Figure 6D ). The reduced levels of endogenous ING4 in this cell line could be reverted after proteasome inhibition (supplementary Figure 6 is available at Carcinogenesis Online). Thus, this set of experiments show that the N214D mutation leads to reduced ING4 protein stability. . 3) . ING4, like other ING proteins, is involved in control of proliferation and apoptosis, but it also has a specific role in restraining additional responses relevant in tumor progression, such as angiogenesis and invasion (4, 5) . In this study, we have examined the functional impact of two point mutations in ING4 found in lung tumor cell lines, in order to understand the contribution of alterations in ING proteins to tumorigenesis (5). Based on our results, using a range of functional assays, we conclude that the N214D mutation markedly dampens ING4 activity. In turn, the Y121N mutation had no significant impact in the normal function of the ING4 protein. In particular, the N214D mutant version of ING4 was less efficient in sensitization to cell death and inhibition of proliferation, cell migration or anchorage-independent growth. The N214 residue is located in the conserved PHD domain, which acts as recognition module for H3K4me3. Therefore, we investigated possible effects of the mutation in several structural and binding parameters of ING4. Our results rule out a significant impact of this mutation in the correct folding of the ING4 PHD domain or in the binding to histone marks, unlike cancer-associated mutations in the same domain of the ING1 protein (35) . While these structural parameters are normal in the N214D mutant, we have not investigated other functions of ING4 in transcription control, such as the association to histone acetyltransferase-histone deacetylase complexes or transcription factors, therefore we cannot at this point rule out alterations in gene regulation associated to the N214D mutant. The most significant alteration observed for the N214D mutant was its reduced protein stability relative of wild-type ING4. A recent report has showed that ING4 protein degradation is mediated by proteasomemediated proteolysis and might be mediated by its accumulation in the nucleolus and its association with the tumor suppressor nucleolar protein ARF (34) . We have confirmed that the degradation of wildtype or mutant ING4 proteins can be reverted with proteasome inhibitors. However, we found that ING4 protein stability could not be correlated with accumulation in nucleolus or colocalization with ARF because wild-type and mutant ING4 consistently showed a uniform nuclear localization pattern. The precise mechanism responsible for the altered protein stability of the N214D mutant is currently not known. Direct inhibition of ubiquitination is unlikely. Although the specific residues that are ubquitinated in ING4 have not been identified, ubiquitination is supposed to occur in the first 180 residues of the protein, distant from the N214 residue (34) . Instead, the N214D mutation might have some effect in the fine tuning of the process, in a similar situation to ING1, where phosphorylation of S126 influences proteasome-mediated protein turnover (36) . Of note, mutations in S126 of ING1 have been found in human tumors (37) , as is the case for N214 of ING4. Interestingly, two very recent reports show that ING2 and ING3, other members of the ING family, are also regulated by proteasome-mediated degradation. In the case of ING3, this control was found altered in melanoma, leading to diminished ING3 protein levels (38, 39) . Therefore, it appears that abnormally decreased protein stability, albeit by different ways of action, might be a general mechanism responsible for defective ING protein function in tumors. It should be noted that, although reduced stability clearly correlates with defective function of N214D mutant, we cannot formally rule out the existence of additional functional defects that could synergize with the aberrant stability to account for the defective tumor suppressive functions of the N214D version. Different types of ING4 alterations have been reported in human tumors. Reduced levels of ING4 RNA and protein are frequently found in many types of tumors, including glioma (7, 17) , myeloma (6), melanoma (30, 40) , breast carcinoma (5), head and neck squamous cell carcinoma (21) or gastric cancer (23) . In some instances, tumors with ING4 downregulation also showed loss-of-heterozygosity at the chromosomal region encompassing the ING4 locus (5, 21) . The molecular mechanism responsible for downregulation of ING4 in those tumors retaining normal ING4 alleles is currently unclear. In many cases, ING4 underexpression is associated with increased angiogenesis, advanced tumor grade and poor prognosis (6, 7, 23, 30, 41) . Truncated forms of the ING4 protein, originating from alternative splicing or frameshift mutations have also been found in primary tumors and tumor cell lines (5, 22, 23) . However, different ING4 splice variants are normally expressed in non-tumor tissue (24) and it is currently unclear whether any of these truncated forms of ING4 are bona fide tumor-specific versions. Interestingly, most of the truncated proteins lack the conserved C-terminal PHD domain and therefore they might act as dominant negatives (7) . The remaining class of ING4 alterations in cancer, which we have studied in our report, are missense mutations found in tumor cell lines (5). Our functional assays indicate that the N214D mutation results in a hypomorphic phenotype, and it does not seem to act as a dominant-negative form because it did not abolish endogenous ING4 function. Interestingly, the N214D mutation was found in a lung carcinoma cell line where the second ING4 allele was also inactivated by a frameshift mutation leading to a truncated ING4 protein (5) . We predict that the presence of these two independent alterations in the ING4 locus renders these cells defective for ING4 function, and this trait has been selected during tumorigenesis. After submission of this manuscript, Kim et al. (42) have reported that a truncated version of ING4 found in human cancer acts as a dominant mutant to promote tumorigenesis. Taken together with our results, these findings highlight the existence of diverse mechanisms for ING4 inactivation in human tumors.
In summary, the current study has revealed that a cancer-associated mutation in ING4 results in abnormally reduced protein stability, which in turn causes defects in several functions of ING4 relevant 
Cancer-associated mutations in ING4
as barriers to tumor initiation and/or progression. These results indicate that the loss of ING4 function confers a selective advantage in tumor formation, and highlight the importance of ING4 in tumor protection.
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